Flupirtine
-
Flupirtine
structure -
-
CAS No:
56995-20-1
-
Formula:
C15H17FN4O2
-
Chemical Name:
Flupirtine
-
Synonyms:
Carbamic acid,N-[2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-,ethyl ester;Carbamic acid,[2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-,ethyl ester;Flupirtine;Katadolon;D 9998;Trancopal Dolo;Ethyl [2-Amino-6-[(4-fluorobenzyl)amino]pyridin-3-yl]carbamate;[2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester
- Categories:
-
CAS No:
Description
N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester is an aminopyridine.|Flupirtine is a pyridine derivative that is in clinical use as a nonopioid analgesic. It was approved for the treatment of pain in 1984 in Europe. It is not approved for use in the U.S. or Canada, but is currently in phase II trials for the treatment of fibromyalgia.
Flupirtine Basic Attributes
304.32
304.13355396
260-503-8
MOH3ET196H
DTXSID4048436
N - Nervous system
Safety Information
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P301+P312, P304+P312, P304+P340, P312, P330, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Toxicity
Oral, mouse: LD50 = 300 mg/kg; Oral, rabbit: LD50 = 3200 mg/kg; Oral, rat: LD50 = 980 mg/kg.
Drug Information
Investigated for use/treatment in fibromyalgia.
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Bioavailability: 90% (oral), 70% (rectal)|72% of flupirtine and its metabolites appear in urine and 18% appear in faeces.
Hepatic to 2-amino-3-acetylamino-6-(para-fluorobenzylamino) pyridine (which has 20-30% the analgesic potential of its parent compound) and Para-fluorohippuric acid.
6.5 hrs (average), 11.2-16.8 hrs (average 14 hrs) (elderly), 8.7-10.9 hrs (average 9.8 hrs) (in those with moderate-level renal impairment).
Flupirtine upregulates Bcl-2, increases glutathione levels, activates an inwardly rectifying potassium channel, and delays loss of intermitochondrial membrane calcium retention capacity. Flupirtine acts like a NMDA receptor antagonists, but does not bind to the receptor. One study concluded that the discriminative effects of flupirtine are neither of opioid nor of alpha-1 adrenergic type, but are primarily mediated through alpha-2 adrenergic mechanisms [PMID: 2901483].
D 9998
Computed Properties
Molecular Weight:304.32
XLogP3:2.4
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:6
Exact Mass:304.13355396
Monoisotopic Mass:304.13355396
Topological Polar Surface Area:89.3
Heavy Atom Count:22
Complexity:350
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Flupirtine maleate
75507-68-5
-
4,4′-(1,2-Diazenediyl)bis[N,N,N-trimethylbenzenaminium]
21704-61-0
-
N-(4-Chloro-2-methylphenyl)formamide
21787-81-5
-
Basic Blue 8 Formula
2185-87-7
-
3-tert-butyl-5-chloro-2-hydroxy-N-(2-nitrosophenyl)benzamide Formula
21889-00-9
-
1-Phenylcyclohexylamine Formula
2201-24-3
-
6-Hydroxymelatonin Structure
2208-41-5
-
Pyrrocaine Structure
2210-77-7
-
What is 2-amino-N-(4-ethoxyphenyl)ethanesulfonamide
22103-30-6
-
What is Bufeniode
22103-14-6